Extracellular vesicles: emerging therapeutic agents for liver fibrosis

Abstract

Liver fibrosis is a progressive condition characterized by excessive scar tissue buildup, leading to impaired liver function and potentially cirrhosis. Despite advancements in treatment strategies, effective anti-fibrotic therapies remain an urgent unmet need. Recent research has identified extracellular vesicles (EVs) as promising therapeutic agents due to their ability to mediate intercellular communication and regulate key fibrotic pathways. This review aims to provide a comprehensive overview of the therapeutic potential of EVs in different in vitro and in vivo models of hepatic fibrosis, focusing on their natural effects and recent advancements in their engineering for enhanced efficacy. EVs can be derived from various cellular sources, including mesenchymal stromal cells (MSCs) and liver-resident cells. Biological materials, including serum, breast milk, bacteria, and plants, also serve as EV sources. Among these, MSC-EVs stand out for their therapeutic potential, which can be significantly enhanced through preconditioning with inflammatory signals, pharmacological agents, or genetic engineering to improve EV quality and efficacy. Engineering techniques have further expanded EV applications, enabling their use as precise and effective drug-delivery vehicles. Approaches such as loading EVs with pharmacological compounds, designing customized EVs, and creating EV-liposome hybrids enable targeted delivery to activated hepatic stellate cells (HSCs), central drivers of fibrosis progression. These strategies enhance the efficacy of EV-based treatments. Both natural and engineered EVs regulate critical pathways of liver fibrosis development, including activation of HSCs, modulation of pro-fibrotic genes, extracellular matrix deposition, and programmed cell death. Additionally, EVs modulate immune responses, fostering a liver microenvironment conducive to repair and regeneration. Combining the natural regenerative properties of EVs with innovative engineering strategies provides highly targeted, effective treatment approaches to restore liver function and address the urgent unmet need for chronic liver disease therapies.

Keywords

Extracellular vesicles / liver fibrosis / hepatic stellate cells / engineered EVs / drug-delivery system

References

[1] Sharma S,Chen JY.Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis.Nat Rev Gastroenterol Hepatol2023;20:662-78

[2] Airola C,Cerrito L.Microvascular thrombosis and liver fibrosis progression: mechanisms and clinical applications.Cells2023;12:1712 PMCID:PMC10341358

[3] Rinella ME,Siddiqui MS.AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease.Hepatology2023;77:1797-835 PMCID:PMC10735173

[4] Ebrahimi H,Sohrabpour AA.New concepts on reversibility and targeting of liver fibrosis; a review article.Middle East J Dig Dis2018;10:133-48 PMCID:PMC6119836

[5] Bruno S,Camussi G.Extracellular vesicles: a therapeutic option for liver fibrosis.Int J Mol Sci2020;21:4255 PMCID:PMC7352992

[6] Wiklander OPB,Lötvall J,El Andaloussi S.Advances in therapeutic applications of extracellular vesicles.Sci Transl Med2019;11:eaav8521 PMCID:PMC7104415

[7] Chong SY,Huang C.Extracellular vesicles in cardiovascular diseases: alternative biomarker sources, therapeutic agents, and drug delivery carriers.Int J Mol Sci2019;20:3272 PMCID:PMC6650854

[8] de Jong OG,Murphy DE.Drug delivery with extracellular vesicles: from imagination to innovation.Acc Chem Res2019;52:1761-70 PMCID:PMC6639984

[9] Théry C,Segura E.Membrane vesicles as conveyors of immune responses.Nat Rev Immunol2009;9:581-93

[10] Welsh JA, Goberdhan DCI, O’Driscoll L, et al; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404. PMCID:PMC10850029

[11] Kalluri R.The biology, function, and biomedical applications of exosomes.Science2020;367:eaau6977 PMCID:PMC7717626

[12] Mori MA,Garcia-Martin R,Kahn CR.Extracellular miRNAs: from biomarkers to mediators of physiology and disease.Cell Metab2019;30:656-73 PMCID:PMC6774861

[13] Ogawa R,Sato M.Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation.Biochem Biophys Res Commun2010;398:723-9

[14] Simons M.Exosomes--vesicular carriers for intercellular communication.Curr Opin Cell Biol2009;21:575-81

[15] Sarvar D, Shamsasenjan K, Akbarzadehlaleh P. Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy.Adv Pharm Bull2016;6:293-9 PMCID:PMC5071792

[16] Berumen J,Kisseleva T.Liver fibrosis: pathophysiology and clinical implications.WIREs Mech Dis2021;13:e1499 PMCID:PMC9479486

[17] Stalnikowitz D, Weissbrod AB. Liver fibrosis and inflammation. A review.Ann Hepatol2003;2:159-63

[18] Tanaka M.Liver regeneration and fibrosis after inflammation.Inflamm Regen2016;36:19 PMCID:PMC5725806

[19] Garbuzenko DV.Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis.World J Clin Cases2022;10:3662-76 PMCID:PMC9100727

[20] Cai X,Wang J.Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy.Pharmacol Res2020;155:104720

[21] Matsuda M.Hepatic stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis.Semin Liver Dis2020;40:307-20 PMCID:PMC7484001

[22] Roehlen N,Baumert TF.Liver fibrosis: mechanistic concepts and therapeutic perspectives.Cells2020;9:875 PMCID:PMC7226751

[23] Iredale JP,Henderson NC.Extracellular matrix degradation in liver fibrosis: biochemistry and regulation.Biochim Biophys Acta2013;1832:876-83

[24] Bonnans C,Werb Z.Remodelling the extracellular matrix in development and disease.Nat Rev Mol Cell Biol2014;15:786-801 PMCID:PMC4316204

[25] Saki S,Ghaffari F.Unraveling the exosome-miR-133a axis: targeting TGF-β signaling via WJ-MSC-derived exosomes for anti-fibrotic therapy in liver fibrosis.Iran Biomed J2024;28:235-44 PMCID:PMC11829155

[26] Afarin R,Shakerian E,Rashidi M.Exosomes of Whartons’ jelly mesenchymal stem cell reduce the NOX genes in TGF-β-induced hepatic fibrosis.Iran J Basic Med Sci2022;25:1498-503 PMCID:PMC9742568

[27] Rashidi M,Monjezi S.Effects of exosomes of mesenchymal stem cells on cholesterol-induced hepatic fibrogenesis.Iran J Basic Med Sci2023;26:695-700 PMCID:PMC10237171

[28] Torabi S,Shekari F.Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles induce liver fibrosis-resolving phenotype in alternatively activated macrophages.J Cell Mol Med2024;28:e18507 PMCID:PMC11407755

[29] Zong R,Yan Y.Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling.Hepatol Int2024;18:1781-91

[30] Li T,Wang B.Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis.Stem Cells Dev2013;22:845-54 PMCID:PMC3585469

[31] Yuan M,Chen P.Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis.Int Immunopharmacol2023;125:111134

[32] Cheng F,Wang Y,Qian H.Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway.J Nanobiotechnology2023;21:195 PMCID:PMC10273609

[33] Wang Y,Yang F.USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway.Pharmacol Res2024;209:107471

[34] Dong L,Chen X.hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice.Stem Cell Res Ther2020;11:21 PMCID:PMC6953150

[35] Huang YJ,Lee CY.Umbilical cord blood plasma-derived exosomes as a novel therapy to reverse liver fibrosis.Stem Cell Res Ther2021;12:568 PMCID:PMC8588641

[36] Jiang W,Cai M.Human umbilical cord MSC-derived exosomes suppress the development of CCl₄-induced liver injury through antioxidant effect.Stem Cells Int2018;2018:6079642 PMCID:PMC5857330

[37] Sani F,Azarpira N.The effect of mesenchymal stem cell-derived exosomes and miR17-5p inhibitor on multicellular liver fibrosis microtissues.Stem Cells Int2023;2023:8836452 PMCID:PMC10421706

[38] Chiabotto G,Ceccotti E,Camussi G.Mesenchymal stromal cell-derived extracellular vesicles for reversing hepatic fibrosis in 3D liver spheroids.Biomedicines2024;12:1849 PMCID:PMC11351945

[39] Tan Y,Mei R.HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis.Cell Death Dis2022;13:319 PMCID:PMC8993870

[40] Tian S,Zhang M.Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages.Stem Cell Res Ther2022;13:330 PMCID:PMC9297598

[41] Shi Y,Wang S.Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model.Stem Cell Res Ther2022;13:517 PMCID:PMC9652856

[42] Zheng W,Qiu S.Placenta mesenchymal stem cell-derived extracellular vesicles alleviate liver fibrosis by inactivating hepatic stellate cells through a miR-378c/SKP2 axis.Inflamm Regen2023;43:47 PMCID:PMC10557276

[43] Alhomrani M,Zavou M.The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis.Front Pharmacol2017;8:748 PMCID:PMC5660722

[44] Ohara M,Hosono H.Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats.Stem Cells Int2018;2018:3212643 PMCID:PMC6323530

[45] Xu AL,Yan J,Wang W.Effects of mesenchymal stem cells-derived extracellular vesicles on inhibition of hepatic fibrosis by delivering miR-200a.Tissue Eng Regen Med2024;21:609-24 PMCID:PMC11087440

[46] Wang N,Zhong Z.3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway.J Nanobiotechnology2021;19:437 PMCID:PMC8686281

[47] Rong X,Yao X,Wang Y.Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway.Stem Cell Res Ther2019;10:98 PMCID:PMC6421647

[48] Rostom DM,Khalifa HM,El Sabaawy EA.The therapeutic potential of extracellular vesicles versus mesenchymal stem cells in liver damage.Tissue Eng Regen Med2020;17:537-52 PMCID:PMC7393001

[49] Sun C,Duan X,Wang B.Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4.Bioengineered2022;13:5915-27 PMCID:PMC8973762

[50] Ma J,Chen M.hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2B.Cell Biol Toxicol2023;39:1-22

[51] An SY,Lim HJ.Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice.Gastroenterology2017;152:1174-86

[52] Didamoony MA,Ahmed LA.Modulatory effect of rupatadine on mesenchymal stem cell-derived exosomes in hepatic fibrosis in rats: a potential role for miR-200a.Life Sci2023;324:121710

[53] Zhao S,Pu Z.Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro.Drug Des Devel Ther2019;13:2887-97 PMCID:PMC6707369

[54] Zhang Y,Nie X.Exosomes derived from BMMSCs mitigate the hepatic fibrosis via anti-pyroptosis pathway in a cirrhosis model.Cells2022;11:4004 PMCID:PMC9776579

[55] Feng X,Zhou J.Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells.Hepatology2025;81:1211-27 PMCID:PMC11902620

[56] Ellakany AR,Shoheib ZS,Ashour DS.Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals.Pathog Glob Health2024;118:429-49 PMCID:PMC11338202

[57] Han HS,You D.Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis.J Control Release2020;320:328-36

[58] Zhang Z,Yang Q.Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism.J Nanobiotechnology2023;21:29 PMCID:PMC9878808

[59] Al Saihati HA,Dessouky AA.Exploring the cytoprotective role of mesenchymal stem cell-derived exosomes in chronic liver fibrosis: insights into the Nrf2/Keap1/p62 signaling pathway.Int Immunopharmacol2024;141:112934

[60] Wu B,Guo J.ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.Stem Cell Res Ther2022;13:494 PMCID:PMC9531400

[61] Du Z,Liu L,Wei C.Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.J Cell Mol Med2021;25:701-15 PMCID:PMC7812282

[62] Gan L,Yao L.Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathway.Cytokine2023;172:156386

[63] Takeda N,Mito M.Analysis of distribution, collection, and confirmation of capacity dependency of small extracellular vesicles toward a therapy for liver cirrhosis.Inflamm Regen2023;43:48 PMCID:PMC10561446

[64] Watanabe T,Takeuchi S.Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles.Regen Ther2020;14:252-61 PMCID:PMC7232114

[65] Kim J,Shin Y.sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p.Mol Ther2021;29:1471-86 PMCID:PMC8058446

[66] Bruno S,Herrera Sanchez MB.HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis.Mol Ther2020;28:479-89 PMCID:PMC7001005

[67] Chiabotto G,Pasquino C.Human liver stem cell-derived extracellular vesicles modulate long non-coding RNA expression profile in an in vivo model of non-alcoholic steatohepatitis.Explor Dig Dis2023;2:172-87

[68] Chiabotto G,Tapparo M,Bruno S.Human liver stem cell-derived extracellular vesicles target hepatic stellate cells and attenuate their pro-fibrotic phenotype.Front Cell Dev Biol2021;9:777462 PMCID:PMC8593217

[69] Hu Z,Jiang J.Exosome-derived miR-142-5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB.Environ Toxicol2023;38:1860-73

[70] Frangogiannis N.Transforming growth factor-β in tissue fibrosis.J Exp Med2020;217:e20190103 PMCID:PMC7062524

[71] Carthy JM.TGFβ signaling and the control of myofibroblast differentiation: implications for chronic inflammatory disorders.J Cell Physiol2018;233:98-106

[72] Russo E,Corrao S.The truth is out there: biological features and clinical indications of extracellular vesicles from human perinatal stem cells.Cells2023;12:2347 PMCID:PMC10571796

[73] Hazrati A,Soudi S.Mesenchymal stromal/stem cells and their extracellular vesicles application in acute and chronic inflammatory liver diseases: emphasizing on the anti-fibrotic and immunomodulatory mechanisms.Front Immunol2022;13:865888 PMCID:PMC9021384

[74] Tan CY,Wong W,Lim SK.Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models.Stem Cell Res Ther2014;5:76 PMCID:PMC4229780

[75] Gómez-Virgilio L,Flores-Morelos DS.Autophagy: a key regulator of homeostasis and disease: an overview of molecular mechanisms and modulators.Cells2022;11:2262 PMCID:PMC9329718

[76] Talukdar S,Emdad L.Autophagy and senescence: insights from normal and cancer stem cells.Adv Cancer Res2021;150:147-208

[77] Mao YQ.Autophagy: a new therapeutic target for liver fibrosis.World J Hepatol2015;7:1982-6 PMCID:PMC4528272

[78] Hazari Y,Hetz C,Kroemer G.Autophagy in hepatic adaptation to stress.J Hepatol2020;72:183-96

[79] Wang C,Gong L.Macrophage polarization and its role in liver disease.Front Immunol2021;12:803037 PMCID:PMC8712501

[80] Arora S,Agarwal B,Syed MA.Macrophages: their role, activation and polarization in pulmonary diseases.Immunobiology2018;223:383-96 PMCID:PMC7114886

[81] Xue JD,Tang AF.Shaping the immune landscape: multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration.Heliyon2024;10:e37192 PMCID:PMC11408064

[82] Hu Q,Fletcher JK,Wan M.Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses.Acta Pharm Sin B2021;11:1493-512 PMCID:PMC8245807

[83] Wang J,Xia M.Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro.Biochim Biophys Acta Mol Basis Dis2024;1870:167020

[84] Chen L,Kemper S.Pathways of production and delivery of hepatocyte exosomes.J Cell Commun Signal2018;12:343-57 PMCID:PMC5842184

[85] Li X,Kemper S.Extracellular vesicles from hepatocytes are therapeutic for toxin-mediated fibrosis and gene expression in the liver.Front Cell Dev Biol2019;7:368 PMCID:PMC6966099

[86] Liu W,Cao H.Human-induced hepatocytes-derived extracellular vesicles ameliorated liver fibrosis in mice via suppression of TGF-β1/smad signaling and activation of Nrf2/HO-1 signaling.Stem Cells Dev2023;32:638-51

[87] Zhong Z,Tan KJ.Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis.J Nanobiotechnology2024;22:541 PMCID:PMC11375929

[88] Povero D,Leszczynska A.Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.JCI Insight2019;5:125652 PMCID:PMC6675559

[89] Wang L,Quan J.Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.Hum Cell2020;33:582-9

[90] Chen L,Kemper S,You H.Therapeutic effects of serum extracellular vesicles in liver fibrosis.J Extracell Vesicles2018;7:1461505 PMCID:PMC5912192

[91] Maeda Y,Ishikawa N.Platelet-rich plasma-derived extracellular vesicles improve liver cirrhosis in mice.Regen Ther2024;26:1048-57 PMCID:PMC11576940

[92] Reif S,Musseri M,Gerstl RG.Beneficial effects of milk-derived extracellular vesicles on liver fibrosis progression by inhibiting hepatic stellate cell activation.Nutrients2022;14:4049 PMCID:PMC9571732

[93] Gong Q,Jiang T.Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice.Front Nutr2022;9:1009139 PMCID:PMC9582986

[94] Kim JS,Kim HW.Hemp sprout-derived exosome-like nanovesicles as hepatoprotective agents attenuate liver fibrosis.Biomater Sci2024;12:5361-71

[95] Keshavarz Azizi Raftar S,Yadegar A.The protective effects of live and pasteurized akkermansia muciniphila and its extracellular vesicles against HFD/CCl4-induced liver injury.Microbiol Spectr2021;9:e0048421 PMCID:PMC8557882

[96] Xu F,Deng J.Rapid and high-efficiency generation of mature functional hepatocyte-like cells from adipose-derived stem cells by a three-step protocol.Stem Cell Res Ther2015;6:193 PMCID:PMC4595267

[97] Zhong Z,Zhu X.Highly efficient conversion of mouse fibroblasts into functional hepatic cells under chemical induction.J Mol Cell Biol2024;15:mjad071 PMCID:PMC11121195

[98] Calzoni E,Cusumano G,Urbanelli L.Plant-derived extracellular vesicles: natural nanocarriers for biotechnological drugs.Processes2024;12:2938

[99] Shao M,Chen S,Feng G.Plant-derived extracellular vesicles -a novel clinical anti-inflammatory drug carrier worthy of investigation.Biomed Pharmacother2023;169:115904

[100] Zhang S,Tan DEL.Gut-liver axis: potential mechanisms of action of food-derived extracellular vesicles.J Extracell Vesicles2024;13:e12466 PMCID:PMC11183959

[101] Yang Y,Yang D.Secretive derived from hypoxia preconditioned mesenchymal stem cells promote cartilage regeneration and mitigate joint inflammation via extracellular vesicles.Bioact Mater2023;27:98-112 PMCID:PMC10063382

[102] Bader AM,Bieback K.Hypoxic preconditioning increases survival and pro-angiogenic capacity of human cord blood mesenchymal stromal cells in vitro.PLoS One2015;10:e0138477 PMCID:PMC4575058

[103] Duijvestein M,Welling MM.Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis.Stem Cells2011;29:1549-58

[104] François M,Li M.Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.Mol Ther2012;20:187-95

[105] Noone C,English K,Mahon BP.IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro.Stem Cells Dev2013;22:3003-14 PMCID:PMC3824722

[106] Ragni E,De Luca P.Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.Stem Cell Res Ther2020;11:165 PMCID:PMC7189600

[107] Lim J,Ju H.Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells.Int J Mol Med2017;40:739-47 PMCID:PMC5547989

[108] Lee S,Lee JH.Ascorbic acid 2-glucoside stably promotes the primitiveness of embryonic and mesenchymal stem cells through ten-eleven translocation- and cAMP-responsive element-binding protein-1-dependent mechanisms.Antioxid Redox Signal2020;32:35-59

[109] Kang H,Lim J.The therapeutic effects of human mesenchymal stem cells primed with sphingosine-1 phosphate on pulmonary artery hypertension.Stem Cells Dev2015;24:1658-71 PMCID:PMC4499788

[110] Damasceno PKF,Santos GC.Genetic engineering as a strategy to improve the therapeutic efficacy of mesenchymal stem/stromal cells in regenerative medicine.Front Cell Dev Biol2020;8:737 PMCID:PMC7471932

[111] Chen S,Qian H,Jiang J.Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy.Stem Cells Int2022;2022:1779346 PMCID:PMC9124131

[112] Takeuchi S,Iwasawa T.Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis.NPJ Regen Med2021;6:19 PMCID:PMC8010072

[113] Bavarsad S, Jalali MT, Bijan Nejad D, Alypoor B, Babaahmadi Rezaei H, Mohammadtaghvaei N. TGFβ1-pretreated exosomes of wharton jelly mesenchymal stem cell as a therapeutic strategy for improving liver fibrosis.Hepat Mon2022;22:e123416

[114] Tawfeek GA.Curcumin preconditioned mesenchymal stem cells derived exosomes transplantation ameliorate and protect against non- alcoholic steatohepatitis by regulation the expression of key genes of inflammation and oxidative stress.Transpl Immunol2023;78:101837

[115] Jiang X,You H.Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways.Int Immunopharmacol2024;142:113162

[116] Lang Z,Lin L.Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.Cell Death Discov2023;9:304 PMCID:PMC10439924

[117] Chen L,Chen DZ.BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis.Mol Immunol2018;93:38-46

[118] Tian X,Li X,Zuo H.Exosomes derived from bone marrow mesenchymal stem cells alleviate biliary ischemia reperfusion injury in fatty liver transplantation by inhibiting ferroptosis.Mol Cell Biochem2024;479:881-94 PMCID:PMC11016128

[119] Xuan J,Li H.Extracellular vesicles from miR-148a-5p-enriched bone marrow mesenchymal stem cells relieve hepatic fibrosis by targeting Smad4.Mol Biotechnol2022;64:535-45

[120] Ma L,Zeng Y.Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis.Drug Deliv2022;29:440-53 PMCID:PMC8812765

[121] Qu Y,Cai X.Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.J Cell Mol Med2017;21:2491-502 PMCID:PMC5618698

[122] Lou G,Liu F.MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.J Cell Mol Med2017;21:2963-73 PMCID:PMC5661245

[123] Yu L,Wu Y.Therapeutic effect of exosomes derived from hepatocyte-growth-factor-overexpressing adipose mesenchymal stem cells on liver injury.Folia Histochem Cytobiol2023;61:160-71

[124] Wang J,Jiang M,Zheng J.Therapeutic potential of exosome derived from hepatocyte growth factor-overexpressing adipose mesenchymal stem cells in TGFβ1-stimulated hepatic stellate cells.Cytotechnology2024;76:217-29 PMCID:PMC10940570

[125] Domínguez LM,Cantero MJ.Chromatographic scalable method to isolate engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of liver fibrosis in mice.Int J Mol Sci2023;24:9586 PMCID:PMC10253331

[126] Fiore E,Bayo J.Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice.Gene Ther2020;27:62-73

[127] Zhu D,Wei J.BMP7-loaded human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate liver fibrosis by targeting activated hepatic stellate cells.Int J Nanomedicine2024;19:3475-95 PMCID:PMC11018131

[128] Wang Y,Yang F.MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression.J Zhejiang Univ Sci B2024;25:594-604 PMCID:PMC11254680

[129] Li T,Han G.The therapeutic potential and clinical significance of exosomes as carriers of drug delivery system.Pharmaceutics2022;15:21 PMCID:PMC9865231

[130] Herrmann IK,Fuhrmann G.Extracellular vesicles as a next-generation drug delivery platform.Nat Nanotechnol2021;16:748-59

[131] Xie H,Zhang L.Mesenchymal stem cell-derived microvesicles support ex vivo expansion of cord blood-derived CD34⁺ cells.Stem Cells Int2016;2016:6493241 PMCID:PMC4799819

[132] Azizsoltani A,Zali MR,Baghaei K.Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling.Biomed Pharmacother2023;168:115777

[133] Niknam B,Mahmoud Hashemi S,Reza Zali M.Human Wharton’s jelly mesenchymal stem cells derived-exosomes enriched by miR-124 promote an anti-fibrotic response in an experimental model of liver fibrosis.Int Immunopharmacol2023;119:110294

[134] Tang M,Li B.Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis.FASEB J2021;35:e21557 PMCID:PMC10851328

[135] Ashour AA,Mehanna RA,Heikal LA.Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis.Drug Deliv2022;29:3270-80 PMCID:PMC9639476

[136] Tang M,Sun M.Effective delivery of osteopontin small interference RNA using exosomes suppresses liver fibrosis via TGF-β1 signaling.Front Pharmacol2022;13:882243 PMCID:PMC9478741

[137] You DG,Nguyen VQ.Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo.J Control Release2021;336:285-95

[138] Yang H,Xiao J.ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis.Biomaterials2025;314:122887

[139] Luo N,Chen Y.Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.Drug Deliv2021;28:10-8 PMCID:PMC7751418

[140] Wan T,Pan Q,Ping Y.Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases.Sci Adv2022;8:eabp9435 PMCID:PMC9473578

[141] Zhao Y,Wang S,Teng L.Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis.Asian J Pharm Sci2022;17:630-40 PMCID:PMC9640367

[142] Yu F,Feng J.Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis.Eur J Pharm Sci2024;198:106783

[143] Gong L,Zhang S.CD44-targeting drug delivery system of exosomes loading forsythiaside a combats liver fibrosis via regulating NLRP3-mediated pyroptosis.Adv Healthc Mater2023;12:e2202228

[144] Gong L,Zhang Y.Preparation of phillygenin-hyaluronic acid composite milk-derived exosomes and its anti-hepatic fibrosis effect.Mater Today Bio2023;23:100804 PMCID:PMC10518489

[145] Albaladejo-García V,Santos-Coquillat A.Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease.Biomed Pharmacother2024;173:116381

[146] Zhang G,Xiu H.Extracellular vesicles: natural liver-accumulating drug delivery vehicles for the treatment of liver diseases.J Extracell Vesicles2020;10:e12030 PMCID:PMC7726052

[147] Cecchin R,Witwer K.Extracellular vesicles: the next generation in gene therapy delivery.Mol Ther2023;31:1225-30 PMCID:PMC10188631

[148] Hu C,Zhang L,Li L.Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury.Stem Cell Res Ther2020;11:377 PMCID:PMC7469278

[149] Chakraborty D,Mallano T.Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis.Nat Commun2017;8:1130 PMCID:PMC5654983

[150] Xiang DM,Ning BF.The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.Gut2018;67:1704-15

[151] Li J,Xu W.Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.Liver Int2015;35:1222-33

[152] Cummins CB,Nunez Lopez O.Luteolin-mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway.Int J Mol Sci2018;19:1567 PMCID:PMC6032316

[153] Lorena D,Gadeau AP.Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.J Hepatol2006;44:383-90

[154] Tang M,Chen S.Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis.Life Sci2021;264:118619

[155] Nevzorova YA,Hu W.Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice.Hepatology2012;56:1140-9 PMCID:PMC3396430

[156] Chiangjong W,Hongeng S.Red blood cell extracellular vesicle-based drug delivery: challenges and opportunities.Front Med2021;8:761362 PMCID:PMC8739511

[157] Rodríguez DA.Extracellular vesicle-based hybrid systems for advanced drug delivery.Pharmaceutics2022;14:267 PMCID:PMC8878585

[158] Piffoux M,Wilhelm C,Tareste D.Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems.ACS Nano2018;12:6830-42

[159] der Koog L, Gandek TB, Nagelkerke A. Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization.Adv Healthc Mater2022;11:e2100639 PMCID:PMC11468589

[160] Zhang YW,Xing JH,Zhou SY.Two-membrane hybrid nanobiomimetic delivery system for targeted autophagy inhibition of activated hepatic stellate cells to synergistically treat liver fibrosis.ACS Appl Mater Interfaces2023:50863-77

[161] Ji K,Huang D.Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity.Biomater Sci2022;10:702-13

[162] Sun D,Cao X.Neutrophil-based bionic delivery system breaks through the capillary barrier of liver sinusoidal endothelial cells and inhibits the activation of hepatic stellate cells.Mol Pharm2024;21:2043-57